Table 2.
Factors | OS | TTR | ||||
---|---|---|---|---|---|---|
Univariate multivariate | Univariate multivariate | |||||
P | HR (95 % CI) | P | P | HR (95 % CI) | P | |
Age (≤53 vs >53) | NS | NA | 0.004 | NS | ||
AFP(≤20 vs >20) | NS | NA | 0.043 | NS | ||
INR (≤1.0 vs >1.0) | 0.010 | NS | NS | NA | ||
PLT counts (≤127 vs >127) | 0.046 | NS | NS | NA | ||
Neutrophil counts | 0.040 | 0.329 (0.174–0.623) | 0.001 | NS | NA | |
Vascular invasion (yes vs no) | NS | NA | 0.001 | 1.757 (1.110–2.781) | 0.016 | |
Tumor size (≤3.0 vs >3.0) | 0.040 | NS | <0.001 | NS | ||
Postoperative TACE (yes vs no) | 0.001 | 2.566 (1.488–4.424) | 0.001 | <0.001 | 2.175 (1.408–3.359) | <0.001 |
Re-operation (yes vs no) | NS | NA | <0.001 | 9.037 (4.970–16.432) | <0.001 | |
NLR (>2.1 vs ≤2.1) | 0.014 | 3.013 (1.633–5.561) | <0.001 | 0.002 | 1.619 (1.057–2.478) | 0.027 |
Univariate analysis Kaplan-Meier method, Multivariate analysis Cox proportional hazards regression model, SHCC small hepatocellular carcinoma, AFP alpha-fetoprotein, INR international normal ratio, PLT platelet, TACE transarterial chemoembolization, NLR neutrophil-to-lymphocyte ratio, OS overall survival, TTR time to recurrence, HR hazard ratio, NS not significant, NA not adopted